Canada markets closed

Lobe Sciences Ltd. (LOBE.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
Add to watchlist
0.0150-0.0050 (-25.00%)
At close: 01:32PM EDT
Full screen
Previous Close0.0200
Open0.0200
Bid0.0150 x N/A
Ask0.0200 x N/A
Day's Range0.0150 - 0.0200
52 Week Range0.0100 - 0.0400
Volume96,383
Avg. Volume34,897
Market Cap1.187M
Beta (5Y Monthly)2.46
PE Ratio (TTM)N/A
EPS (TTM)-0.0300
Earnings DateApr 26, 2024 - Apr 30, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Business Wire

    Lobe Sciences Provides Company Review of 2023

    VANCOUVER, British Columbia, January 08, 2024--Lobe Sciences Ltd. (OTCQB: LOBEF) (CSE: LOBE) ("Lobe" or the "Company"), a biopharmaceutical company focused on developing transformative medicines to treat rare diseases today provided an update from the Company on its progress and achievements in 2023.

  • Business Wire

    Lobe Sciences Provides Update on L-130 Clinical Program

    VANCOUVER, British Columbia, December 07, 2023--Lobe Sciences Ltd. (OTCQB: LOBEF) (CSE: LOBE) ("Lobe" or the "Company"), a biopharmaceutical company focused on developing transformative medicines to treat rare diseases today provided an update from the Company’s lead clinical program, L-130, a proprietary stabilized psilocin conjugate drug candidate. The Phase 1 study (NCT06035900) was an open label clinical trial in 10 normal and healthy individuals designed to determine the safety and pharmaco

  • Business Wire

    Lobe Sciences Provides Update on L-130 Oral Psilocin Compound

    VANCOUVER, British Columbia, December 05, 2023--Lobe Sciences Reports 12 Months Stability for Lead Psilocin Drug Candidate (L-130).